Compare ASMB & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | GLAD |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 429.7M |
| IPO Year | 2010 | 2001 |
| Metric | ASMB | GLAD |
|---|---|---|
| Price | $23.53 | $19.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $44.20 | $22.33 |
| AVG Volume (30 Days) | ★ 296.9K | 142.3K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 9.78% |
| EPS Growth | 91.78 | ★ 91.82 |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.16 |
| Revenue Next Year | $638.39 | $5.10 |
| P/E Ratio | ★ N/A | $19.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.80 | $16.54 |
| 52 Week High | $39.71 | $21.89 |
| Indicator | ASMB | GLAD |
|---|---|---|
| Relative Strength Index (RSI) | 27.73 | 45.77 |
| Support Level | $21.80 | $19.19 |
| Resistance Level | $30.36 | $19.44 |
| Average True Range (ATR) | 1.48 | 0.28 |
| MACD | -0.64 | -0.03 |
| Stochastic Oscillator | 3.01 | 35.53 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.